Marimed (MRMD) Total Current Liabilities (2011 - 2026)
Marimed (MRMD) posted quarterly Total Current Liabilities of $63.8 million for Q1 2026, up 15.28% year-over-year from $55.3 million in Q1 2025, and up 7.94% quarter-over-quarter from $59.1 million in Q4 2025.
Marimed (MRMD) Total Current Liabilities (2011 - 2026) Analysis & Trends
Marimed (MRMD) has reported Total Current Liabilities for 16 consecutive years, with $63.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Current Liabilities rose 15.28% year-over-year to $63.8 million; the TTM figure through Mar 2026 stood at $63.8 million (up 15.28% YoY), while the FY2025 annual figure was $59.1 million, up 18.12% from the prior year.
- Total Current Liabilities climbed to $63.8 million in Q1 2026 per MRMD's latest filing, from $59.1 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $63.8 million in Q1 2026 and bottomed at $24.5 million in Q1 2023.
- Historically, Total Current Liabilities has averaged $40.6 million across 5 years, with a median of $35.5 million in 2024.
- Annual changes were most pronounced in 2022 — Total Current Liabilities soared 134.89% — and 2023, when it fell 28.3%.
- Marimed's Total Current Liabilities stood at $26.5 million in 2022, then climbed by 16.5% to $30.9 million in 2023, then jumped by 62.03% to $50.0 million in 2024, then gained by 18.12% to $59.1 million in 2025, then gained by 7.94% to $63.8 million in 2026.
- Business Quant data shows MRMD's Total Current Liabilities at $63.8 million in Q1 2026, $59.1 million in Q4 2025, and $56.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | -8.38 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 15.65 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 2.06 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 17.34 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 6.35 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 874.50 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 1.85 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 1.79 Bn |
| 10 | Marimed | 27.77 Mn | 19.33 Mn | 16.23 Mn | 63.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 63.75 Mn |
| Mar 31, 2026 | 63.76 Mn |
| Dec 31, 2025 | 59.07 Mn |
| Sep 30, 2025 | 56.58 Mn |
| Jun 30, 2025 | 50.94 Mn |
| Mar 31, 2025 | 55.31 Mn |
| Dec 31, 2024 | 50.01 Mn |
| Sep 30, 2024 | 44.60 Mn |
| Jun 30, 2024 | 40.66 Mn |
| Mar 31, 2024 | 35.46 Mn |
| Dec 31, 2023 | 30.86 Mn |
| Sep 30, 2023 | 35.29 Mn |
| Jun 30, 2023 | 29.23 Mn |
| Mar 31, 2023 | 24.51 Mn |
| Dec 31, 2022 | 26.49 Mn |
| Sep 30, 2022 | 27.25 Mn |
| Jun 30, 2022 | 25.21 Mn |
| Mar 31, 2022 | 34.19 Mn |
| Dec 31, 2021 | 27.22 Mn |
| Sep 30, 2021 | 22.46 Mn |